In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Patients taking Novo Nordisk's Wegovy obesity treatment maintained an average of 10% weight loss after four years, ...
Novo Nordisk (NVO) claims it retains only 60% of list price of weight loss drugs Ozempic and Wegovy after payments to pharma ...
Novo Nordisk's (NVO) obesity therapy Wegovy cut adverse kidney-related events by 22% in obese and overweight individuals in a ...
Researchers highlighted on Monday that certain genes may help identify patients with obesity who are most likely to respond ...
The data could go some way to convince insurers and governments to reimburse Wegovy. Read more at straitstimes.com.
The results shed light on the long-term effects of Wegovy, and could boost Novo Nordisk’s case to insurers and governments to ...
A Novo spokesperson said in a statement to Reuters that the new analysis “demonstrates for the first time the benefits of ...
Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has ...
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis ...
Following is a summary of current health news briefs. Novo blames US health system after criticism over Wegovy price, ...
Patients sometimes have to stop using GLP-1 medications like Ozempic and Wegovy and risk regaining lost weight.